PHSA 19296 Linear Accelerators, Service and Software
Solicitation number BCPHSA_19296
Publication date
Closing date and time 2026/07/03 15:00 EDT
Description
Notice of Intent to Direct Award
Issued: June 23, 2026
File # PHSA 19296
NOI Title: Linear Accelerators, Service and Software
Provincial Health Services Authority
Notice is hereby given that “the Provincial Health Services Authority (“PHSA”), on behalf of the BC Cancer Agency, intends to directly award a strategic partnership agreement in radiation oncology to the below supplier, which, amongst other value propositions, will allow for the provision of Linear Accelerators and associated service and software support for a term of ten (10) years at an estimated value of $75,000,000.
SIEMENS HEALTHCARE LIMITED
386 Broadway, Suite 705
Winnipeg, Manitoba
R3C 3R6
PHSA has chosen not to proceed with a competitive process for the following reason:the goods or services can be supplied only by the selected supplier and no alternative or substitute exists for the following reason:to ensure compatibility with existing products/systems Building on a long-standing relationship with Siemens in radiation oncology, BC Cancer intends to maximize the value through investments already made through establishing a more fulsome strategic partnership with this supplier to ensure the continuity and long-term sustainability of radiation therapy services across British Columbia. Given that the current provincial Linear Accelerator fleet is standardized on technology and proprietary software architecture, hardware configurations, this supplier’s integrated service model is deeply embedded within existing clinical workflows, treatment planning systems, and quality assurance processes. Transitioning to an alternate provider would introduce significant interoperability risks, potential treatment disruptions, extensive retraining requirements, and duplicative capital costs, all of which could compromise patient care and system reliability.
Establishing a 10‑year strategic agreement enables coordinated lifecycle management of capital assets, including timely replacement and upgrades, consistent software enhancements aligned with evolving clinical standards, and guaranteed access to specialized Siemens technical expertise, parts, and support. This approach supports operational stability, mitigates clinical and operational risk, optimizes total cost of ownership, and ensures the province can continue to deliver safe, high-quality radiation therapy services without interruption.
Moreover, by formalizing the relationship with Siemens through this agreement, BC Cancer is provided an opportunity to identify unmet clinical needs across the Provincial BC Cancer Program—including re-development sites - to shape a 10-year strategic roadmap. This includes positioning BC Cancer at the forefront of next generation therapies which is in the best interests of patients in the Province of BC.
Suppliers who wish to challenge this decision should submit a detailed written objection for the attention of Manish Chauhan and Austy Joseph, Buyer, by email to manish.chauhan@phsa.ca and austy.joseph@phsa.ca before 12:00pm Pacific Time, July 3, 2026. PHSA will review any and all issues received by this date and provide due consideration to each objection.
Please Reference File: PHSA 19296 on all written correspondence.
Issued: June 23, 2026
File # PHSA 19296
NOI Title: Linear Accelerators, Service and Software
Provincial Health Services Authority
Notice is hereby given that “the Provincial Health Services Authority (“PHSA”), on behalf of the BC Cancer Agency, intends to directly award a strategic partnership agreement in radiation oncology to the below supplier, which, amongst other value propositions, will allow for the provision of Linear Accelerators and associated service and software support for a term of ten (10) years at an estimated value of $75,000,000.
SIEMENS HEALTHCARE LIMITED
386 Broadway, Suite 705
Winnipeg, Manitoba
R3C 3R6
PHSA has chosen not to proceed with a competitive process for the following reason:the goods or services can be supplied only by the selected supplier and no alternative or substitute exists for the following reason:to ensure compatibility with existing products/systems Building on a long-standing relationship with Siemens in radiation oncology, BC Cancer intends to maximize the value through investments already made through establishing a more fulsome strategic partnership with this supplier to ensure the continuity and long-term sustainability of radiation therapy services across British Columbia. Given that the current provincial Linear Accelerator fleet is standardized on technology and proprietary software architecture, hardware configurations, this supplier’s integrated service model is deeply embedded within existing clinical workflows, treatment planning systems, and quality assurance processes. Transitioning to an alternate provider would introduce significant interoperability risks, potential treatment disruptions, extensive retraining requirements, and duplicative capital costs, all of which could compromise patient care and system reliability.
Establishing a 10‑year strategic agreement enables coordinated lifecycle management of capital assets, including timely replacement and upgrades, consistent software enhancements aligned with evolving clinical standards, and guaranteed access to specialized Siemens technical expertise, parts, and support. This approach supports operational stability, mitigates clinical and operational risk, optimizes total cost of ownership, and ensures the province can continue to deliver safe, high-quality radiation therapy services without interruption.
Moreover, by formalizing the relationship with Siemens through this agreement, BC Cancer is provided an opportunity to identify unmet clinical needs across the Provincial BC Cancer Program—including re-development sites - to shape a 10-year strategic roadmap. This includes positioning BC Cancer at the forefront of next generation therapies which is in the best interests of patients in the Province of BC.
Suppliers who wish to challenge this decision should submit a detailed written objection for the attention of Manish Chauhan and Austy Joseph, Buyer, by email to manish.chauhan@phsa.ca and austy.joseph@phsa.ca before 12:00pm Pacific Time, July 3, 2026. PHSA will review any and all issues received by this date and provide due consideration to each objection.
Please Reference File: PHSA 19296 on all written correspondence.
Contract duration
Refer to the description above for full details.
Trade agreements
-
Please refer to tender description or tender documents
Contact information
Contracting organization
- Organization
-
Provincial Health Services Authority (Incl. BCCSS)
- Email
- manish.chauhan@phsa.ca
Bidding details
Full details for this tender opportunity are available on a third-party site
Click on the button below to be directed to this website. Note that on the third-party site you may need an account to view and/or bid on this tender. Information on any fees or additional costs to access the full details is outlined in the Description tab of this tender opportunity.